📰 Mark Swallow News
Page 3 - Mark Swallow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Swallow. Real-time updates on events, politics, business and more.
November 21, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") desires to share more information with the Companys shareholders...
November 21, 2022
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...
November 16, 2022
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug...
November 10, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,...
November 10, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY JURISDICTION IN WHICH...
November 10, 2022
Memory CD8+ T cell response found as early as two weeks after the first administration of EO2401, expanding to up to 5% of circulating specific CD8+ T cells in some patients Immunological
November 10, 2022
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug...
November 7, 2022
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug...
November 7, 2022
/PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T cell directed immunotherapies against unconventional, shared, cancer-specific antigens,...
November 3, 2022
OSLO, Norway, Nov. 3, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces the progress it has made in designing and developing a portfolio